---

Type 3 diabetes (T3D) and alzheimer’s disease (AD)

---

Review Article

Author Details : Mahesh Shivananjappa*

Volume : 4, Issue : 1, Year : 2022

Article Page : 8-12

https://doi.org/10.18231/j.ctppc.2022.003

Suggest article by email

Get Permission

---

Abstract

Alzheimer’s disease (AD) is being referred as Type-3-Diabetes (T3D) as both have similar molecular and cellular features but it’s still in a debate. Progression of Type 2 Diabetes Mellitus (T2DM) is called AD. AD is also called “diabetes of the brain”.Insulin degrading enzyme (IDE) is very important in the shift of T2DM to T3D. Biochemical and molecular abnormalities of AD are mitochondrial dysfunction, chronic oxidative stress, amyloid-β deposits, neurofibrillary tangles, cell loss, dystrophic neurites, increased activation of signalling pathways and pro-death genes. This review aims to explain all these structural and molecular similarities between T3D and AD.

Keywords: Type 3 Diabetes (T3D), Alzheimer's disease (AD), Type 2 Diabetes Mellitus (T2DM)

How to cite : Shivananjappa M, Type 3 diabetes (T3D) and alzheimer’s disease (AD). Curr Trends Pharm Pharm Chem 2022;4(1):8-12

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.